Effects of SVF and exosome in covid-19 patients with acute respiratory distress syndrome
Phase 2
Recruiting
- Conditions
- Covid19.
- Registration Number
- IRCT20200510047385N1
- Lead Sponsor
- Tabriz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
covid19 patients hospitalized in the ICU, which includes all confirmatory tests –
Satisfaction in studying
Exclusion Criteria
History of kidney transplantation
History surgery on the lungs
The presence of any malignancy
Previous active infection
Use immunosuppressive and other drugs
The presence of autoimmune disease
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Evaluation of inflammatory status IL1,. Timepoint: per 3 days. Method of measurement: Eliza.
- Secondary Outcome Measures
Name Time Method